Getinge said Tuesday it will phase out its surgical perfusion business and reallocate resources to higher-growth areas such as extracorporeal membrane oxygenation (ECMO) and transplant care. CEO ...
STOCKHOLM (Reuters) - Sweden's Getinge (GETIb.ST) said on Thursday it had agreed to sell its troubled surgical mesh business that saw the medical equipment maker swing to a loss in the third quarter ...
Getinge (OM:GETI B) plans significant board changes at its 2026 AGM. Shareholders are set to vote on the election of Camilla Sylvest to the board. New employee representatives are also expected to ...
Narrow-moat Getinge GETI B reported third-quarter earnings above our expectations. We are increasing our fair value estimate to SEK 247 from SEK 221, as Getinge is executing a turnaround in its acute ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S. (Reuters) ...
In its second acquisition of 2023—and its largest in several years—Swedish devicemaker Getinge has set its sights on High Purity New England, which churns out a range of products used throughout the ...
GÖTEBORG, Sweden, July 24, 2020 /PRNewswire/ -- Today Getinge announces its intention to become a CO₂neutral company by 2025. The target will be reached by a stepwise approach in several areas and ...
GETINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Getinge Group (STO:GETIB) has recently performed a strategic review to clarify its long-term strategy for ensuring sustainable and profitable growth.
GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- Born 12 weeks too early with a 50/50 chance at survival, Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and ...
Medical device maker Getinge is recalling 41 of its Cardiohelp Emergency Drive life support machines due to the risk of the device’s emergency drive becoming stuck when clinicians attempt to activate ...
The FDA is instructing healthcare facilities to avoid using two heart devices from Getinge amid concerns that the company has not adequately resolved issues that spurred a string of recalls over the ...
Organ preservation and transport company Paragonix Technologies has agreed to be acquired through a $477 million deal offered by Getinge—which expects the international transplant market to continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results